ENvue Medical, Inc.FEEDEarnings & Financial Report
Nasdaq
NextMar 31, 2026
FEED Q3 2025 Key Financial Metrics
Revenue
$722.0K
Gross Profit
$189.0K
Operating Profit
$-2.2M
Net Profit
$510.0K
Gross Margin
26.2%
Operating Margin
-311.2%
Net Margin
70.6%
YoY Growth
92.0%
EPS
$-0.91
Financial Flow
ENvue Medical, Inc. Q3 2025 Financial Summary
ENvue Medical, Inc. reported revenue of $722.0K for Q3 2025, with a net profit of $510.0K (70.6% margin). Cost of goods sold was $533.0K, operating expenses totaled $2.4M.
Key Financial Metrics
| Total Revenue | $722.0K |
|---|---|
| Net Profit | $510.0K |
| Gross Margin | 26.2% |
| Operating Margin | -311.2% |
| Report Period | Q3 2025 |
ENvue Medical, Inc. Annual Revenue by Year
ENvue Medical, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.6M).
| Year | Annual Revenue |
|---|---|
| 2024 | $2.6M |
| 2023 | $2.3M |
| 2022 | $752.0K |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2M | $921000 | $817000 | $376000 | $444000 | $1.0M | $494000 | $722000 |
| YoY Growth | 1253.9% | 160.2% | 177.9% | -17.9% | -62.3% | 11.3% | -39.5% | 92.0% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $6.7M | $6.2M | $5.7M | $4.7M | $3.6M | $44.1M | $51.5M | $54.4M |
| Liabilities | $2.7M | $2.7M | $2.9M | $2.8M | $3.0M | $8.4M | $11.0M | $11.9M |
| Equity | $4.0M | $3.5M | $2.8M | $1.9M | $627000 | $35.7M | $40.5M | $42.5M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-491000 | $-579000 | $-553000 | $-836000 | $-548000 | $-1.3M | $-3.4M | $-2.0M |